Tradestie Institutional Equity Comparison Engine · Market Close Nov 20, 2026

BKD vs ADUS: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

ADUS Wins Head-to-Head Institutional Verdict (3–2 across 6 Pillars · 9–1 Matrix Metrics)

ADUS Overall Winner 6-Pillar Tally: BKD 2 – 3 ADUS (1 Tie) Matrix Metrics: BKD 1 – 9 ADUS

As of Nov 20, 2026, Addus HomeCare Corp. (ADUS) is the stronger overall head-to-head candidate over Brookdale Senior Living, Inc. (BKD) in the Tradestie Institutional Equity Comparison Engine, winning 9–1 core matrix metrics and 3–2 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). BKD carries a Unified Composite Score of 62.0/100 (BUY) at $8.86 (78.4x Forward P/E, 6.2% operating margin), whereas ADUS carries 59.0/100 (HOLD) at $122.50 (16.1x Forward P/E, 10.4% operating margin).

  • Composite vs. Pillar Nuance: While BKD currently prints a higher short-term Unified Composite Score (62.0/100 BUY vs. ADUS 59.0/100 HOLD), ADUS captures the overall institutional head-to-head verdict (9–1 matrix metrics and 3–2 across the 6 pillars) due to superior fundamental profitability (10.4% vs. 6.2% operating margin) and revenue trajectory (+7.0% vs. -9.0% YoY).
  • Technical & Structure Timing Caution: BKD is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 38.1); meanwhile ADUS trades in a Markup technical trend (UNCLASSIFIED options phase, RSI 51.6). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About BKD vs ADUS
BKD NYSE
Brookdale Senior Living, Inc.
Services-Nursing & Personal Care Facilities
$8.86
+1.96% 1D
Market Cap $2.1B
TTM Revenue $2.86B
Forward P/E 78.4x
Beta / 30D Vol 0.23β · 73% Vol
Unified Composite Score
62.0 / 100 BUY
Tech 91.0 Fund 73.0 Flow 50.0 Mom 78.9
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -8.7%), weak momentum, RSI 38
RSI-14: 38.1 · SMA20: $9.58 · SMA50: $10.30
ADUS NASDAQ Head-to-Head Winner
Addus HomeCare Corp.
Services-Home Health Care Services
$122.50
+1.18% 1D
Market Cap $2.3B
TTM Revenue $1.50B
Forward P/E 16.1x
Beta / 30D Vol -0.07β · 21% Vol
Unified Composite Score
59.0 / 100 HOLD
Tech 57.0 Fund 52.0 Flow 50.0 Mom 46.0
Weinstein Technical Phase Markup · Hold / add on dips
Price above SMA50, rising 50-day trend (1.9% over 20 days), RSI 52
RSI-14: 51.6 · SMA20: $123.87 · SMA50: $118.74

6-Pillar Scorecard Institutional Category Breakdown (BKD 2 – 3 ADUS)

Columns: Metric · BKD · ADUS
1. Valuation Multiples ADUS
Forward P/E 78.4x 16.1x
Trailing P/E 66.2x 20.1x
PEG Ratio 0.28x 1.05x
EV / Revenue 0.7x 1.5x
2. Growth & Scale ADUS
Revenue Growth (YoY) -9.0% +7.0%
Earnings Growth (YoY) +0.0% +24.2%
TTM Revenue (USD) $2.86B $1.50B
Market Cap $2.1B $2.3B
3. Profitability & Quality ADUS
Gross Margin 28.7% 32.3%
Operating Margin 6.2% 10.4%
Net Profit Margin -1.3% 7.4%
Return on Equity (ROE) -349.6% 10.0%
4. Balance Sheet & Cash Flow BKD
Cash Generation (TTM) $473M EBITDA $173M EBITDA
Cash Flow Margin 16.5% EBITDA Mgn 11.5% EBITDA Mgn
Net Cash / Leverage -349.6% ROE $64.64 Book/Sh · 10.0% ROE
Dividend Yield None (0.00%) None (0.00%)
5. Options & Positioning Tie
Options Structure Phase UNCLASSIFIED UNCLASSIFIED
Current IV / %ile 45.2% (6th %ile) 21.9% (16th %ile)
Put/Call OI Skew N/A N/A
OBV Trend / Tech Phase NEUTRAL · Markdown NEUTRAL · Markup
6. R&D & Supply-Chain Moat BKD
OpEx & R&D Intensity 22.5% of Rev ($644M) 21.9% of Rev ($329M)
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Cyclical / Execution-Driven Positioning Cyclical / Execution-Driven Positioning
Supply-Chain Role Medical Care Facilities Operator Medical Care Facilities Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: BKD (1) vs ADUS (9)
Institutional Metric BKD ADUS Criterion Row Edge
Market Capitalization
Scale
$2.1B $2.3B Larger Scale ADUS
Trailing P/E Ratio
Valuation
66.2x 20.1x Lower Multiple ADUS
Forward P/E Ratio
Valuation
78.4x 16.1x Lower Multiple ADUS
Revenue Growth (YoY)
Growth
-9.0% +7.0% Higher Growth ADUS
Operating Margin (TTM)
Profitability
6.2% 10.4% Higher Margin ADUS
Net Profit Margin
Profitability
-1.3% 7.4% Higher Margin ADUS
Return on Equity (ROE)
Capital Efficiency
-349.6% 10.0% Higher ROE ADUS
52-Week Range Position
Momentum
4% ($9–$17) 79% ($88–$132) Stronger Trend ADUS
Beta / 30D Volatility
Risk Regime
0.23β · 73% Vol -0.07β · 21% Vol Lower Realized Risk ADUS
Unified Institutional Score
Composite Signal
62.0 / 100 (BUY) 59.0 / 100 (HOLD) Higher Composite BKD
Trailing 12M Revenue (USD)
Operating Scale
$2.86B $1.50B FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
28.7% 32.3% Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
0.28x PEG · 0.7x EV/Rev 1.05x PEG · 1.5x EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
$473M EBITDA (-349.6% ROE) $173M EBITDA ($64.64 Book/Sh · 10.0% ROE) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon ADUS +12.91 pp
BKD: -13.05% · ADUS: -0.14%
3M Horizon ADUS +28.29 pp
BKD: -26.9% · ADUS: +1.39%
6M Horizon ADUS +65.6 pp
BKD: -33.38% · ADUS: +32.22%
1Y Horizon ADUS +27.93 pp
BKD: -15.54% · ADUS: +12.39%

Financial Trajectory Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant USD Revenue & Operating Margin (%)

Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on BKD vs ADUS. Trailing 12-month operating profitability (BKD 6.2% vs ADUS 10.4%) and valuation multiples (BKD 78.4x vs ADUS 16.1x Forward P/E) are benchmarked directly in Pillar 4 below.

BKD ADR TTM Benchmark FX-Normalized USD
TTM Revenue$2.86B
Gross Margin28.7%
Op. Margin6.2%
ROE / Fwd P/E-349.6% · 78.4x
ADUS ADR TTM Benchmark FX-Normalized USD
TTM Revenue$1.50B
Gross Margin32.3%
Op. Margin10.4%
ROE / Fwd P/E10.0% · 16.1x

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
BKD UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV 45.2%
IV Percentile 6th %ile
Put/Call OI Skew N/A
IV Regime Compressed (<25th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact BKD Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
ADUS UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV 21.9%
IV Percentile 16th %ile
Put/Call OI Skew N/A
IV Regime Compressed (<25th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact ADUS Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
BKD Moat Profile Cyclical / Execution-Driven Positioning
Medical Care Facilities Operator
Competes within the Medical Care Facilities value chain with $2.1B market capitalization and 6.2% operating margin.
OpEx & R&D Reinvestment 22.5% of Rev ($644M)
90D Engineering Disclosures 0 Published
ADUS Moat Profile Cyclical / Execution-Driven Positioning
Medical Care Facilities Operator
Competes within the Medical Care Facilities value chain with $2.3B market capitalization and 10.4% operating margin.
OpEx & R&D Reinvestment 21.9% of Rev ($329M)
90D Engineering Disclosures 0 Published

Investor FAQ BKD vs ADUS Key Questions & Quantitative Answers

As of Nov 20, 2026, Addus HomeCare Corp. (ADUS) is the stronger overall head-to-head candidate over Brookdale Senior Living, Inc. (BKD) in the Tradestie Institutional Equity Comparison Engine, winning 9–1 core matrix metrics and 3–2 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). BKD carries a Unified Composite Score of 62.0/100 (BUY) at $8.86 (78.4x Forward P/E, 6.2% operating margin), whereas ADUS carries 59.0/100 (HOLD) at $122.50 (16.1x Forward P/E, 10.4% operating margin). Composite vs. Pillar Nuance: While BKD currently prints a higher short-term Unified Composite Score (62.0/100 BUY vs. ADUS 59.0/100 HOLD), ADUS captures the overall institutional head-to-head verdict (9–1 matrix metrics and 3–2 across the 6 pillars) due to superior fundamental profitability (10.4% vs. 6.2% operating margin) and revenue trajectory (+7.0% vs. -9.0% YoY). Technical & Structure Timing Caution: BKD is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 38.1); meanwhile ADUS trades in a Markup technical trend (UNCLASSIFIED options phase, RSI 51.6). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

ADUS leads the Growth & Scale pillar: BKD posts -9.0% YoY revenue growth and +0.0% YoY earnings growth on $2.86B TTM revenue (28.7% gross margin, 6.2% operating margin), compared with ADUS at +7.0% YoY revenue growth and +24.2% YoY earnings growth on $1.50B TTM revenue (32.3% gross margin, 10.4% operating margin). On trailing 12-month operating scale, BKD generates $2.86B in USD-normalized revenue versus $1.50B for ADUS. In operating R&D and SG&A reinvestment, BKD deploys 22.5% of Rev ($644M) (0 90-day corporate R&D disclosures) versus 21.9% of Rev ($329M) (0 disclosures) for ADUS.

ADUS screens cheaper on headline valuation multiples. BKD trades at 78.4x Forward P/E, 66.2x Trailing P/E, 0.28x PEG, and 0.7x EV/Revenue (16.5% EBITDA margin), whereas ADUS trades at 16.1x Forward P/E, 20.1x Trailing P/E, 1.05x PEG, and 1.5x EV/Revenue (11.5% EBITDA margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against BKD (-349.6% ROE) versus ADUS (10.0% ROE) capital efficiency.

In options market volatility and institutional positioning, BKD carries 45.2% implied volatility (6th %ile, Compressed (<25th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.23β · 73% Vol realized risk). By comparison, ADUS carries 21.9% implied volatility (16th %ile, Compressed (<25th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (-0.07β · 21% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 20, 2026. For educational research only; not investment advice.